Overview

Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Praga formulation in the treatment of neuropathic pain.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Pregabalin